Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Groarke

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection FractionFawaz Naeem, Teresa C Leone, Christopher Petucci, et al.
Journal of Cardiac Failure|January 17, 2018
Clinical Significance of Early Fluid and Weight Change During Acute Heart Failure HospitalizationJohn D Groarke, Susanna R Stevens, Robert J Mentz, et al.
Cardio-Oncology (London, England)|March 11, 2020
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case seriesSarju Ganatra, Anju Nohria, Sachin Shah, et al.
Journal of Cardiac Failure|May 3, 2016
Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network TrialsJustin M Vader, Shane J LaRue, Susanna R Stevens, et al.
JACC. Heart Failure|October 5, 2019
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term OutcomesElke Platz, Ross T Campbell, Brian Claggett, et al.
Journal of the American Heart Association|November 16, 2020
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated MyocarditisZsofia D Drobni, Amna Zafar, Leyre Zubiri, et al.
The New England Journal of Medicine|September 16, 2024
Ponsegromab for the Treatment of Cancer CachexiaJohn D Groarke, Jeffrey Crawford, Susie M Collins, et al.
Journal of the American College of Cardiology|September 3, 2013
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation Tomas G Neilan, Ravi V Shah, Siddique A Abbasi, et al.
JACC. Cardiooncology|October 31, 2024
Autonomic Dysfunction Among Adult Survivors of Childhood Cancer in the St. Jude Lifetime Cohort StudyJohn D Groarke, Kirsten K Ness, Rikeenkumar Dhaduk, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection FractionFawaz Naeem, Teresa C Leone, Christopher Petucci, et al.
Journal of Cardiac Failure|January 17, 2018
Clinical Significance of Early Fluid and Weight Change During Acute Heart Failure HospitalizationJohn D Groarke, Susanna R Stevens, Robert J Mentz, et al.
Cardio-Oncology (London, England)|March 11, 2020
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case seriesSarju Ganatra, Anju Nohria, Sachin Shah, et al.
Journal of Cardiac Failure|May 3, 2016
Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network TrialsJustin M Vader, Shane J LaRue, Susanna R Stevens, et al.
JACC. Heart Failure|October 5, 2019
Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term OutcomesElke Platz, Ross T Campbell, Brian Claggett, et al.
Journal of the American Heart Association|November 16, 2020
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated MyocarditisZsofia D Drobni, Amna Zafar, Leyre Zubiri, et al.
The New England Journal of Medicine|September 16, 2024
Ponsegromab for the Treatment of Cancer CachexiaJohn D Groarke, Jeffrey Crawford, Susie M Collins, et al.
Journal of the American College of Cardiology|September 3, 2013
The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation Tomas G Neilan, Ravi V Shah, Siddique A Abbasi, et al.
JACC. Cardiooncology|October 31, 2024
Autonomic Dysfunction Among Adult Survivors of Childhood Cancer in the St. Jude Lifetime Cohort StudyJohn D Groarke, Kirsten K Ness, Rikeenkumar Dhaduk, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
Pageof 6